March 22-23, 2019 -Miami, FL, USA-Biltmore Hotel, Coral Gables - LINNC.com
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
LINNC SEMINAR - AMERICAS EDITION
LINNC Seminar is a LINNC extension
a Unique Concept with the Same Spirit!
Photo courtesy of the Greater Miami Convention and Visitors Bureau, MiamiandBeaches.com
PROGRAM
March 22-23, 2019
Biltmore Hotel, Coral Gables
-Miami, FL, USA-
Live Interventional Neuroradiology, Neurology & Neurosurgery Course
www.linnc.com
LINNC SEMINAR 2019 - AMERICAS EDITION
COURSE LINNC US Seminar is transformed – and LINNC Americas is born!
Finally, the Americas – all the Americas – have their own interventional
DIRECTORS
neuroradiology seminar!
By popular demand, our well-received North American course, LINNC US seminar is
expanding its horizons, transforming and becoming LINNC Americas 2019 and taking place
in Miami!
This new venue offers the very best for all our participants. Besides being known for its
good weather and beautiful beaches, Miami is a leading global city with a reputation in
Jacques MORET science, research and the arts – a multicultural and dynamic location for LINNC Americas.
Well served and offering an easier access to our colleagues from throughout South, Central
and North America, our move is in response to what we have heard from participants during
our other seminars and underlines the international and cross-border nature of the work
we advance together.
Interventional neuroradiology has entered a new maturity and with that comes a renewed
commitment from all of us at the LINNC family of neuroradiology, neurology and
neurosurgery courses to ensure that the quality of information and the expertise gained
from years of practice is effectively transmitted and openly exchanged. To do this, we
Laurent SPELLE continually work to develop the curriculum and fine-tune our pedagogical approach so that
those who participate in any LINNC seminar come away with a take-home experience that
can immediately and positively influence their practice.
Aside from offering a venue for all our colleagues throughout the Americas, the central
and motivating force in LINNC Americas will be this very spirit that equally defines all LINNC
seminars:
• An open exchange of knowledge and experience;
• The quality, quantity and diversity of the pre-recorded cases. This case library ensures
Guiseppe LANZINO that the interaction with the audience and expert panels will be strengthened by
concrete examples designed to illustrate the most complex situations and respond to
any of your questions;
• The willingness of all participants, from the leading professors to youngest fellows to
learn together.
This is the LINNC spirit and this is – with your participation – why we believe LINNC Americas
will be the leading course for interventional neuroradiology, neurology and neurosurgery in
the Western Hemisphere!
We wish you a fruitful seminar.
Sincerely,
Course Directors
FACULTY
FACULTY & SCIENTIFIC COMMITTEE
Andres ARBELAEZ Alejandro BERENSTEIN Orlando M. DIAZ
Hospital Pablo Tobón Uribe Cerebrovascular Center Institute for Academic Medicine,
Universidad CES The Mount Sinai Hospital Houston Methodist Hospital
Medellin, Colombia New York, USA Weill Cornell Medical College
Houston, USA
Michel FRUDIT Tudor G. JOVIN Giuseppe LANZINO
Hospital Albert Einstein Cooper University Hospital Mayo Clinic
Sao Paulo, Brazil Camden, USA Rochester, USA
Luis A. LEMME PLAGHOS Italo LINFANTE Vitor MENDES PEREIRA
CENBA - Consultorio Endovascular Miami Cardiac and Vascular Institute Toronto Western Hospital,
Neurologico Buenos Aires Florida International University University Health Network
Buenos Aires, Argentina Miami, USA University of Toronto
Toronto, Canada
Jacques MORET Raul G. NOGUEIRA Ronie Leo PISKE
NEURI, the Brain Vascular Center Marcus Stroke & Neuroscience Center Beneficencia Portuguesa de sao Paulo
Bicêtre Hospital - Paris Saclay University Grady Memorial Hospital Sao Paulo, Brazil
Paris, France Atlanta, USA
Elias RABAHI Laurent SPELLE
Hospital Santa Mônica NEURI, the Brain Vascular Center
Goiânia, Brazil Bicêtre Hospital - Paris Saclay University
Paris, France
3
FRIDAY 22 MARCH 2019
EXPERT PANEL: Jacques MORET, Laurent SPELLE, Andres ARBELAEZ, Alejandro BERENSTEIN, Orlando M. DIAZ,
Vitor MENDES PEREIRA, Raul G. NOGUEIRA, Ronie Leo PISKE, Elias RABAHI
8:00-12:40 MORNING
8:00 Welcome message - Jacques MORET, Laurent SPELLE
8:10 Presentation
of the best cases submitted by attendees
- “Y-stentriever” thrombectomy: dealing with a hard clot in basilar tip occlusion Lucas SCOTTA CABRAL, Brazil
- Pseudo-occlusion and two exceptions to the rule Eytan RAZ, United States
REC 8:30 Recorded
Cases & Cases Discussion 90 min
Brain AVM: Adult & Pediatric
10:00 Coffee break & Visit of the exhibition area
REC 10:30 Recorded
Cases & Cases Discussion 100 min
Ischemic stroke and Aneurysm treatment
12:10 Industry sponsored Symposium* (See page 7)
12:40 Lunch Break
13:30-18:25 AFTERNOON
REC 13:30 Recorded
Cases focused on radial approach
60 min
Aneurysm treatment
14:30 Industry sponsored Symposium* (See page 7)
REC 15:00 Recorded
Cases & Cases Discussion
55 min
Aneurysm management
15:55 Coffee break & Visit of the exhibition area
16:25 Presentation of the best cases submitted by attendees
- Anterior communicating artery embolization with two braided stents in “X” Elias RABAHI, Brazil
- Endovascular occlusion of a complex MCA aneurysm through an ineffective Vitaly KISELEV, Russia
double barrel bypass using FD
- Combined endovascular and microsurgical approach for a left opercular AVM Stephanie LENCK, France
- Mechanical Thrombectomy in a patient with previously treated Stephen GUERIN, United States
giant fusiform aneurysm
- Complex - Transitional basilar aneurysm treated with multiple FD’s telescoped: Boris PABON, Colombia
Staged or Single session?
- Posterior circulation flow diversion & delayed hemorrhage - Autopsy findings Ansaar T. RAI, United States
REC 17:25 Recorded
Cases & Cases Discussion 60 min
Dural AV Fistula & Aneurysm management
*These sessions do not offer continuing education credit
4
SATURDAY 23 MARCH 2019
Michel FRUDIT, Tudor G. JOVIN, Giuseppe LANZINO, Luis A. LEMME PLAGHOS, Italo LINFANTE,
8:00-12:30 MORNING
8:00 Presentation
of the best cases submitted by attendees
- Atypical aneurysm, atypical course, atypical treatment? Guilherme DABUS, United States
- eCLIPs alternative for Intrasaccular ineligible cases Donald RICCI, Canada
- Flow diversion in small vessels: how far can we go? Emanuele ORRU’, Canada
REC 8:30 Recorded
Cases & Cases Discussion
90 min
Ischemic stroke and Aneurysm treatment
10:00 Coffee break & Visit of the exhibition area
10:30 Industry sponsored Symposium* (See page 7)
REC 10:45 Recorded
Cases & Cases Discussion
75 min
Brain AVM & Aneurysm treatment
12:00 Industry sponsored Symposium* (See page 7)
12:30 Lunch Break
13:30-18:00 AFTERNOON
REC 13:30 Recorded
Cases & Cases Discussion
120 min
Ischemic stroke & Dural AVF
15:30 Coffee break & Visit of the exhibition area
16:00 Presentation of the best cases submitted by attendees
- Spinal AVF secondary to venous hypertension from pelvic AVF Charles A. RITCHIE, United States
and a proposal for modified spinal AVF classification
- Endovascular treatment with flow diverter stent Marco Antonio OCHOA SOLORZANO, Mexico
of recanalized aneurysm with unexpected evolution
- Endovascular bail-out after massive rupture for elective basilar tip aneurysm coiling David VOLDERS, Canada
- Endovascular treatment of a ruptured vertebral artery fusiform Matthew TAON, United States
aneurysm in the setting of contralateral subclavian steal
REC 16:40 Recorded
Cases & Cases Discussion 60 min
Miscellaneous
17:40 Award of the best case submitted
17:50 Closing remarks
*These sessions do not offer continuing education credit
5
LEARNING OBJECTIVES
Upon completion of this activity, the learner should be able to:
-Describe the indications of treatment for aneurysms, AVMs, specific AVMs such as of those of the marrow (spine
and spinal cord), spinal dural AVMs; the management of complications, cerebral stroke, and also on percutaneous
techniques and balance the beneficial outcomes from treatment procedures, endovascular or surgical, against the
natural history of the disease.
-Demonstrate the high-quality practice of interventional neuroradiology and neurosurgery in a team environment.
-Review information regarding basic and clinical research in diseases, including techniques and technologies of
interventional neuroradiology and neurosurgery.
-Explain the role of imaging in the diagnosis and management of those neurovascular disorders.
EDUCATIONAL METHODS
• Lectures • Question and Answer Sessions
• Recorded cases • Round Table Discussions
• Audiovisual Presentations
ACCREDITATION STATEMENT
In support of improving patient care, this activity is planned and implemented by Mayo Clinic
College of Medicine and Science, Live Interventional Neuroradiology & Neurosurgery Course
(LINNC) and NEURI Brain Vascular Centre. Mayo Clinic College of Medicine and Science is
jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME),
the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses
Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CREDIT STATEMENT
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of
14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate
with the extent of their participation in the activity.
AMA/ROYAL COLLEGE CANADA
The American Medical Association (AMA) and the Royal College of Physicians and
Surgeons of Canada (Royal College) have renewed their CME agreement. Under the
new agreement, select activities approved for Royal College MOC Credits are eligible for
conversion to AMA PRA Category 1 Credit ™.
National Specialty Societies and Simulation Programs that have been approved by the
Royal College as accredited CPD providers are covered by this agreement.
UEMS/EACCME CME CREDIT RECOGNITION
The American Medical Association (AMA) has an agreement of mutual recognition of
continuing medical education (CME) credit with the European Union of Medical Specialties
(UEMS). Under the terms of this agreement, renewed in 2010, the AMA will convert CME
credit for live and e-learning activities certified by the European Accreditation Council for
Continuing Medical Education (EACCME), the accrediting arm of the UEMS, to AMA PRA
Category 1 Credit ™. European physicians can earn their ECMEC®s by attending live
events that have been certified for AMA PRA Category 1 Credits ™.
DISCLOSURES
Each faculty member, including moderators and planning committee members, in the CME activity are required to
complete a disclosure form. A copy of the MCSCPD Faculty Disclosure Policy is available in the congress bag.
6
E-POSTERS AREA
• Did you know that all best cases submitted by attendees presented on stage, are also viewable in the E-POSTERS
AREA located in the exhibition?
• In addition, come and discover 8 clinical cases selected as E-posters:
- Endovascular treatment of dural sinus thrombosis.
J.J. GUTIERREZ BAÑOS, Colombia
- Direct puncture and percutaneous nBCA embolization of a traumatic head and neck pseudoaneurysm.
D. VOLDERS, Canada
- Distal posterior communicating artery acute occlusion treated with mechanical thrombectomy
J. KOVOOR, United States
- Transvenous embolization of a ruptured thalamic AVM.
S. LENCK, France
- Staged X Stenting for a large ruptured Acom Aneurysm.
S. LENCK, France
- One patient, two endovascular techniques and three treated intracranial aneurysms in one session.
G. SAAL, Perú
- Giant MCA Aneurysm treated with FD: the importance of Windkessel Effect.
B.PABÓN, Colombia
- A Subarachoid Hemorrhage Before Christmas.
V.M. PEREIRA, Canada
INDUSTRY SPONSORED SYMPOSIA
FRIDAY 22 MARCH 2019
12:10 - 12:40 - Industry sponsored Symposium - MicroVention
Evolving treatment of wide neck bifurcation aneurysms.
Ansaar T. RAI, United States
14:30 - 15:00 - Industry sponsored Symposium - Medtronic
Objectives: data spotlight on safety and efficacy of Pipeline in small and medium ICA aneurysms from the PREMIER trial
- Breaking Data- PREMIER Trial Results on Pipeline in Small and Medium Aneurysms.
Ricardo A. HANEL, United States
SATURDAY 23 MARCH 2019
10:30 - 10:45 - Industry sponsored Symposium - Cerenovus
PULSERIDER the Houston Experience. Orlando M. DIAZ, United States
12:00 - 12:30 - Industry sponsored Symposium - Stryker
Committed to Next Gen Innovation.
- Next generation aspiration with AXS Vecta 74. Sudhakar SATTI, United States
- S urpass Flow Diverter: A retrospective experience of 248 patients treated with 1 year follow up.
Shahran DERAKHSHANI, United kingdom
7
Ingest more.
The AXS Vecta 74 Aspiration Catheter is the fi rst
extra-large bore aspiration catheter on the market,
providing a 0.074in lumen designed to ingest the clot.
AXS Vecta™ 74
Aspiration Catheter
Redefine aspiration.
Copyright © 2019 Stryker
AP002436 v1.0
AXS Vecta™ Aspiration Catheter AXS Vecta 6. This device is coated with a hydrophilic coating at the
Catheter part Vessel size in mm proximal end of the device for a length of 25 cm. Please
RX ONLY Aspiration number (Vessel size in inches) refer to the Device Preparation Section for further
Caution: Federal Law (USA) restricts this device to sale by or Catheter
information on how to prepare and use this device to
on the order of a physician. INC-11129-115 2.1-4mm (0.083in – 0.157in) ensure it performs as intended. Failure to abide by the
See package insert for complete indications, AXS Vecta 71 INC-11129-125 2.1-4 mm (0.083in – 0.157in) warnings in this labeling might result in damage to the
contraindications, warnings and instructions for use. INC-11129-132 2.1-4 mm (0.083in – 0.157in) device coating, which may necessitate intervention or
INTENDED USE/INDICATIONS FOR USE INC-11597-115 2.2-4 mm (0.087in – 0.157in) result in serious adverse events.
The AXS Vecta Aspiration System, including the AXS Vecta AXS Vecta 74 INC-11597-125 2.2-4 mm (0.087in – 0.157in) PRECAUTIONS
Aspiration Catheter, Aspiration Tubing Set, and VC-701 INC-11597-132 2.2-4 mm (0.087in – 0.157in) 1. Store in a cool, dry, dark place.
Cliq Aspirator Pump, is indicated in the revascularization of 2. Do not use kinked, damaged, or opened devices.
patients with acute ischemic stroke secondary to intracranial CONTRAINDICATIONS
3. Use the device prior to the “Use By” date specified on
large vessel occlusive disease (within the internal carotid, The AXS Vecta Aspiration Catheter has not been evaluated for the package.
middle cerebral – M1 and M2 segments, basilar, and vertebral use in the coronary vasculature.
Do not use automated high-pressure contrast injection 4. Exposure to temperatures above 54°C (130°F) may damage
arteries) within 8 hours of symptom onset. Patients who are device. Do not autoclave.
ineligible for intravenous tissue plasminogen activator (IV t-PA) equipment with the AXS Vecta Aspiration Catheter because it
or who failed IV t-PA therapy are candidates for treatment. may damage the device. 5. Torqueing or moving the device against resistance may
result in damage to the vessel or device.
DEVICE DESCRIPTION ADVERSE EVENTS 6. Maintain a constant infusion of appropriate flush solution.
The AXS Vecta Aspiration System consist of the AXS Vecta • Acute vessel occlusion 7. If flow through the device becomes restricted, do not
Aspiration Catheter, the Aspiration Tubing Set, and the VC-701 • Air embolism attempt to clear the lumen by infusion. Remove and
Cliq Aspirator Pump. • Allergic reaction and anaphylaxis from contrast media replace the device.
The AXS Vecta Aspiration Catheter is a single lumen, flexible, • Arteriovenous fistula 8. Examine the device to verify functionality and to ensure
variable stiffness catheter. It has a radiopaque marker band • Death that its size and shape are suitable for the specific
on the distal end and a Luer hub at the proximal end. The AXS • Device malfunction procedure for which it is to be used.
Vecta Aspiration Catheter shaft has a lubricious hydrophilic 9. The AXS Vecta Aspiration Catheter should be used only
coating at the distal end (distal • Distal embolization
• Emboli by physicians trained in percutaneous procedures and/or
25 cm) to reduce friction during use. The Scout Introducer may interventional techniques.
be used in conjunction with the AXS Vecta Aspiration Catheter • False aneurysm formation
to facilitate in the introduction of the AXS Vecta Aspiration • Hematoma or hemorrhage at the puncture site 10. The Scout Introducer should be used with a guidewire and
Catheter into distal vasculature and aid in navigation to distal • Inability to completely remove thrombus microcatheter inserted when in vasculature.
anatomy. The Scout Introducer has a lubricious hydrophilic • Infection 11. If using the AXS Vecta Aspiration Catheter for
coating at the distal end to reduce friction during use. thrombectomy, monitor the canister fluid level and replace
• Intracranial hemorrhage the canister if the fill level reaches 75% of the canister
The inner lumen of the AXS Vecta Aspiration Catheters • Ischemia
is compatible with the Scout Introducer, guide wires and volume
micro catheters. The inner lumen of the Scout Introducer is • Kidney damage from contrast media 12. Administration of anticoagulants and antiplatelets should
compatible with guide wires and micro catheters of an outer • Neurological deficit including stroke be suspended until 24 hours post-treatment. Medical
diameter of less than 0.044in. • Risks associated with angiographic and fluoroscopic management and acute post stroke care should follow the
Each package includes one AXS Vecta Aspiration Catheter, one radiation including but not limited to: alopecia, burns ASA guidelines.
Scout Introducer, one hemostasis valve, and two peel-away ranging in severity from skin reddening to ulcers, cataracts, 13. Any neurological determination should be evaluated
introducers. Dimensions of the AXS Vecta Aspiration Catheter and delayed neoplasia by urgent CT scan and other evaluations as indicated
and Scout Introducer are included on the individual device • Sterile inflammation or granulomas at the access site according to investigator/hospital best practice.
label. The AXS Vecta Aspiration Catheters are available in • Tissue necrosis 14. As in all surgical interventions, monitoring of intra-
3 different lengths, the device configurations including the • Vessel spasm, thrombosis, dissection or perforation procedural blood loss is recommended so that appropriate
length of the Scout packaged with each catheter and the WARNING management may be instituted.
recommended Microcatheter length is presented in the table 15. Limit the usage of the AXS Vecta Aspiration Catheter to
Contents supplied STERILE using an ethylene oxide (EO)
1.0 below. arteries greater than the catheter’s outer diameter.
process. Do not use if sterile barrier is damaged. If damage
is found, call your Stryker Neurovascular representative. 16. Excessive aspiration with the distal tip of the AXS Vecta
INC- INC- INC- INC- INC- INC- For single use only. Do not reuse, reprocess or resterilize. Aspiration Catheter covered by the vessel wall may cause
Catheter part Reuse, reprocessing or resterilization may compromise vessel injury. Carefully investigate location of the distal tip
11129 11129 11129 11597 11597 11597
number under fluoroscopy prior to aspiration.
-115 -125 -132 -115 -125 -132 the structural integrity of the device and/or lead to device
fail-ure which, in turn, may result in patient injury, illness or 17. There is an inherent risk with the use of angiography and
Catheter inner death. Reuse, reprocessing or resterilization may also create fluoroscopy.
0.071 0.071 0.071 0.074 0.074 0.074
diameter (in) a risk of contamination of the device and/or cause patient 18. When transporting the VC-701 Cliq pump, utilize the
Distal catheter infection or cross-infection, including, but not limited to, the pump handle.
outer diameter 0.082 0.082 0.082 0.083 0.083 0.083 transmission of infectious disease(s) from one patient to
(in) another. Contamination of the device may lead to injury, illness
Catheter or death of the patient. After use, dispose of product and
working length 115 125 132 115 125 132 packaging in accordance with hospital, administrative and/or
(cm) local government policy.
Scout WARNINGS
Introducer 133 143 150 133 143 150
length (cm) 1. The AXS Vecta Aspiration Catheter has not been evaluated
for more than one (1) clot retrieval attempt.
Recommended
compatible 2. The AXS Vecta Aspiration Catheter was evaluated for an
150 160 160 150 160 160 average duration of direct aspiration of 4 minutes.
microcatheter
length (cm) 3. This product is intended for single use only, do not re-
Recommended sterilize or reuse. Re-sterilization and/or reuse may result in
compatible cross contamination and/or reduced performance.
0.044 0.044 0.044 0.044 0.044 0.044 4. When the catheter is exposed to the vascular system,
microcatheter max max max max max max it should be manipulated while under high-quality
outer diameter
(in) fluoroscopic observation. Do not advance or retract
Recommended the catheter if resistance is met during manipulation;
compatible 0.038 0.038 0.038 0.038 0.038 0.038 determine the cause of the resistance before proceeding.
guidewire outer max max max max max max 5. Operators should take all necessary precautions to limit
diameter (in) X-Radiation doses to patients and themselves by using
sufficient shielding, reducing fluoroscopy times, and
The AXS Vecta Aspiration System is recommended for use in modifying X-Ray technical factors where possible.
the following vessel size ranges based on non-clinical testing.
Refer to Table 2.0 below.
Stryker Neurovascular
47900 Bayside Parkway
Fremont, CA 94538
strykerneurovascular.com
Date of Release: FEB/2019
Copyright © 2019 Stryker
AP002436 v1.0 EX_EN_US
Live Interventional Neuroradiology, Neurology & Neurosurgery Course
JUNE 3 - 5, 2019
PARIS - FRANCE
c arrousel du louvre
SAVE THE DATE
Toronto Paris
Beijing
New
Dehli
LIVE
CENTERS
COURSE DIRECTORS
Santiago
de Chile
Jacques MORET Laurent SPELLE
www.linnc.comEXHIBITION FLOOR PLAN
COURTYARD
GRANADA
BALLROOM
COURTYARD
COURTYARD
Conference Room
Lunch & Coffee Break Area
E-POSTERS ALHAMBRA
AREA BALLROOM 7
Exhibit Spaces
1 6
COURTYARD
2 3 4 5
LOBBY
ELEVATORS
Welcome Desk
MARBELLA ROOM*
MAIN BUILDING
Entrance Hotel
WE THANK OUR PARTNERS FOR THEIR SUPPORT
Exhibitors
Platinum sponsors 7 BALT
MEDTRONIC with an Educational Grant
5 BIOMODEX
MICROVENTION with an Educational Grant
3 CERENOVUS
Gold sponsor
1 MICROVENTION
CERENOVUS with an Educational Grant
STRYKER with an Educational Grant 4 PHILIPS
2 SIM&CURE
6 STRYKER
Marbella Room*
Demonstration / Meeting Room - MICROVENTION
15You can also read
